The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27054295 |
136 |
2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases. |
Forman Christian College (A Chartered University) |
| 24215819 |
17 |
Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. |
Comsats Institute of Information Technology |
| 32212732 |
147 |
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73. |
Arcus Biosciences |
| 32045236 |
34 |
2-Substituted ?,?-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes. |
University of Bonn |
| 30895781 |
69 |
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors. |
National Institute of Diabetes and Digestive and Kidney Diseases |
| 30798051 |
25 |
Lead optimization and biological evaluation of fragment-based cN-II inhibitors. |
Universit£ |
| 30176535 |
10 |
CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates. |
Universit£ |
| 28835785 |
5 |
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases. |
Therachem Research Medilab (India) |
| 32935104 |
12 |
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease as a Clinical Candidate for the Potential Treatment of COVID-19. |
Pfizer |
Search and Browse
